Patients should be counselled that experiencing some gastrointestinal discomfort during Wegovy initiation is common and does not indicate a drug interaction or treatment failure
As AFib continues to affect more patients worldwide, clinicians need new strategies to reduce risk and improve long-term outcomes, presenting author Kenneth Bilchick, MD, professor of cardiovascular medicine at the University of Virginia, explained in a statement These findings suggest GLP-1-RAs may influence heart rhythm through mechanisms beyond weight loss
Push the plunger down to inject the air into the vial
Assess whether Ozempic is a suitable and safe treatment for you
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
However, weight loss from Ozempic might